Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-22

Clinical Trial Update: Prevalence of Germline Alterations in Actionable Genes in Endometrial Cancer [NA]

View source ↗

Summary

This clinical trial aims to determine the prevalence of germline alterations in actionable genes among patients with endometrial cancer and is not yet recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: European Institute of Oncology | Conditions: Endometrial Cancer | NA | Status: NOT_YET_RECRUITING